NASDAQ:ASRT

Assertio Therapeutics Stock Insider Trading

Healthcare > Drug Manufacturers - Specialty & Generic

Buy ASRT

*Your capital is at risk

$23.50

+0 (+0%)

At Close: Aug 04, 2026

Assertio Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 1.39. In total, the insiders bought 2.62M and sold 846.21K ASRT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	1.39
● Buy	2.62M shares
● Sell	846.21K shares
43% Buy Activity Moderate Negative Correlation
Sell Signal Low Confidence Jun 16, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Emany Sravan Kumar Director	Director	5 415 Value: $82.0K
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Emany Sravan Kumar Director	Director	5 415 Value: $50.1K
Jun 16, 2026 Sell	Common Stock U-Tender	Schwichtenberg Paul President And COO	CEO / President	13 987 Value: $0
Jun 16, 2026 Sell	Restricted Stock Units D-Return	Schwichtenberg Paul President And COO	CEO / President	32 042 Value: $0
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Schwichtenberg Paul President And COO	CEO / President	15 666 Value: $307.8K
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Schwichtenberg Paul President And COO	CEO / President	22 666 Value: $269.6K
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Schwichtenberg Paul President And COO	CEO / President	12 591 Value: $153.3K
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Schwichtenberg Paul President And COO	CEO / President	27 888 Value: $328.2K
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Stark David Matthew Director	Director	5 415 Value: $50.1K
Jun 16, 2026 Sell	Common Stock U-Tender	Patel Ajay EVP And CFO	C-Suite Officer	15 942 Value: $0
Jun 16, 2026 Sell	Restricted Stock Units D-Return	Patel Ajay EVP And CFO	C-Suite Officer	26 026 Value: $0
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Patel Ajay EVP And CFO	C-Suite Officer	15 666 Value: $307.8K
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Patel Ajay EVP And CFO	C-Suite Officer	22 666 Value: $269.6K
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Patel Ajay EVP And CFO	C-Suite Officer	12 591 Value: $153.3K
Jun 16, 2026 Sell	Stock Option (Right to Buy) D-Return	Patel Ajay EVP And CFO	C-Suite Officer	21 128 Value: $248.7K
May 13, 2026 Sell	Common Stock G-Gift	Mason Heather L Director	Director	6 666 Value: $0
May 13, 2026 Buy	Common Stock G-Gift	Mason Heather L Director	Director	6 666 Value: $155.5K
May 05, 2026 Buy	Common Stock A-Award	Stark David Matthew Director	Director	4 851 Value: $107.5K
May 05, 2026 Buy	Common Stock A-Award	Emany Sravan Kumar Director	Director	4 851 Value: $107.5K
May 05, 2026 Buy	Common Stock A-Award	Kirk Sigurd Director	Director	4 851 Value: $107.5K
May 05, 2026 Buy	Common Stock A-Award	Mckee William Director	Director	4 851 Value: $107.5K
May 05, 2026 Buy	Common Stock A-Award	Mason Heather L Director	Director	4 851 Value: $107.5K
Mar 02, 2026 Buy	Restricted Stock Units A-Award	Patel Ajay EVP And CFO	C-Suite Officer	18 804 Value: $221.3K
Mar 02, 2026 Buy	Stock Option (right to buy) A-Award	Patel Ajay EVP And CFO	C-Suite Officer	21 128 Value: $248.7K
Mar 02, 2026 Buy	Restricted Stock Units A-Award	Schlessinger Sam EVP, General Counsel	Officer	18 804 Value: $221.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ASSERTIO THERAPEUTICS INC.

Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides CAMBIA, ...

Read Full Profile Here